Privia Health Group, Inc. (NASDAQ:PRVA) Given Consensus Recommendation of “Buy” by Analysts

Shares of Privia Health Group, Inc. (NASDAQ:PRVA) have earned a consensus rating of “Buy” from the thirteen brokerages that are currently covering the company, Marketbeat Ratings reports. One investment analyst has rated the stock with a hold rating, eleven have issued a buy rating and one has given a strong buy rating to the company. The average 1 year price target among brokers that have issued ratings on the stock in the last year is $27.77.

Several analysts recently weighed in on PRVA shares. Barclays increased their target price on Privia Health Group from $23.00 to $24.00 and gave the company an “equal weight” rating in a research note on Tuesday, May 27th. JPMorgan Chase & Co. increased their target price on Privia Health Group from $29.00 to $32.00 and gave the company an “overweight” rating in a research note on Wednesday, May 28th. Truist Financial increased their target price on Privia Health Group from $27.00 to $28.00 and gave the company a “buy” rating in a research note on Thursday, April 10th. Needham & Company LLC reaffirmed a “buy” rating and set a $30.00 price objective on shares of Privia Health Group in a research report on Thursday, April 10th. Finally, Robert W. Baird upped their price objective on shares of Privia Health Group from $24.00 to $26.00 and gave the company an “outperform” rating in a research report on Tuesday, April 15th.

Insider Buying and Selling

In related news, CEO Parth Mehrotra sold 15,100 shares of the firm’s stock in a transaction that occurred on Wednesday, April 30th. The stock was sold at an average price of $23.33, for a total transaction of $352,283.00. Following the completion of the transaction, the chief executive officer owned 454,281 shares in the company, valued at $10,598,375.73. This trade represents a 3.22% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Matthew Shawn Morris sold 10,309 shares of the firm’s stock in a transaction that occurred on Wednesday, April 30th. The stock was sold at an average price of $23.33, for a total value of $240,508.97. Following the transaction, the director owned 59,792 shares of the company’s stock, valued at $1,394,947.36. This trade represents a 14.71% decrease in their position. The disclosure for this sale can be found here. Insiders sold 45,949 shares of company stock worth $1,100,368 in the last 90 days. 10.70% of the stock is owned by company insiders.

Hedge Funds Weigh In On Privia Health Group

Hedge funds and other institutional investors have recently modified their holdings of the stock. CWM LLC lifted its position in shares of Privia Health Group by 50.3% during the 1st quarter. CWM LLC now owns 1,804 shares of the company’s stock worth $40,000 after buying an additional 604 shares during the period. Bessemer Group Inc. increased its holdings in Privia Health Group by 2,393.4% during the 1st quarter. Bessemer Group Inc. now owns 2,269 shares of the company’s stock valued at $51,000 after purchasing an additional 2,178 shares in the last quarter. EverSource Wealth Advisors LLC increased its holdings in Privia Health Group by 7,833.3% during the 4th quarter. EverSource Wealth Advisors LLC now owns 2,380 shares of the company’s stock valued at $47,000 after purchasing an additional 2,350 shares in the last quarter. Russell Investments Group Ltd. increased its holdings in Privia Health Group by 2,852.2% during the 1st quarter. Russell Investments Group Ltd. now owns 2,657 shares of the company’s stock valued at $60,000 after purchasing an additional 2,567 shares in the last quarter. Finally, GAMMA Investing LLC increased its holdings in Privia Health Group by 113.1% during the 1st quarter. GAMMA Investing LLC now owns 2,866 shares of the company’s stock valued at $64,000 after purchasing an additional 1,521 shares in the last quarter. Institutional investors own 94.48% of the company’s stock.

Privia Health Group Stock Performance

PRVA opened at $22.11 on Wednesday. The company has a market cap of $2.70 billion, a PE ratio of 184.27, a price-to-earnings-growth ratio of 3.54 and a beta of 0.82. The stock has a 50-day moving average of $23.08 and a 200-day moving average of $22.92. Privia Health Group has a 52-week low of $16.47 and a 52-week high of $26.09.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.